1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Cell and Gene Therapy Manufacturing Services Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Cell and Gene Therapy Manufacturing Services Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase In the outsourcing of Cell and Gene Therapy Manufacturing
5.2 Market Opportunities
- 5.2.1 The Emergence of resourceful Service Providers
5.3 Future Trends
- 5.3.1 Tech transfer to expand the capabilities by biopharmaceutical players
5.4 Impact of Drivers and Restraints
6. Europe Cell and Gene Therapy Manufacturing Services Market Regional Analysis
6.1 Europe Cell and Gene Therapy Manufacturing Services Market Overview
6.2 Europe Cell and Gene Therapy Manufacturing Services Market Revenue 2020-2030 (US$ Million)
6.3 Europe Cell and Gene Therapy Manufacturing Services Market Forecast Analysis
7. Europe Cell and Gene Therapy Manufacturing Services Market Analysis – by Type
7.1 Cell Therapy
- 7.1.1 Overview
- 7.1.2 Cell Therapy: Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Cell and Gene Therapy Manufacturing Services Market Analysis – by Indication
8.1 Cancer
- 8.1.1 Overview
- 8.1.2 Cancer: Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Orthopedics
- 8.2.1 Overview
- 8.2.2 Orthopedics: Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Cell and Gene Therapy Manufacturing Services Market Analysis – by Application
9.1 Clinical Manufacturing
- 9.1.1 Overview
- 9.1.2 Orthopedics: Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Commercial Manufacturing
- 9.2.1 Overview
- 9.2.2 Orthopedics: Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Cell and Gene Therapy Manufacturing Services Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 UK: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
- 10.1.1.1.2 UK: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
- 10.1.1.1.3 UK: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
- 10.1.1.2 Germany:
Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Germany: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
- 10.1.1.2.2 Germany: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
- 10.1.1.2.3 Germany: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
- 10.1.1.3 France:
Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 France: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
- 10.1.1.3.2 France: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
- 10.1.1.3.3 France: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
- 10.1.1.4 Russia:
Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Russia: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
- 10.1.1.4.2 Russia: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
- 10.1.1.4.3 Russia: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
- 10.1.1.5 Italy:
Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Italy: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
- 10.1.1.5.2 Italy: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
- 10.1.1.5.3 Italy: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
- 10.1.1.6 Rest of Europe:
Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
- 10.1.1.6.2 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
- 10.1.1.6.3 Rest of Europe: Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Cell and Gene Therapy Manufacturing Services Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Catalent Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Charles River Laboratories International Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 FUJIFILM Holdings Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Lonza Group AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Merck KgaA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Nikon Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Oxford BioMedica Plc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Takara Bio Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Thermo Fisher Scientific Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 WuXi AppTec Co Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Europe Cell and Gene Therapy Manufacturing Services Market
